Poor quality medicines a global threat: Scientists

Image
IANS New York
Last Updated : Apr 21 2015 | 2:48 PM IST

With globalisation blurring the line between domestic and foreign medicine production, poor quality medicines are a real and urgent global threat, says a new research.

In global studies of about 17,000 drug samples, 41 percent of specimens failed to meet quality standards, the researchers reported.

Prevalence of poor quality medicines could undermine decades of successful efforts to combat HIV/AIDS, malaria and tuberculosis.

"Today's medical-product landscape blurs the line between domestic and foreign production, drawing attention to the need for global quality and safety oversight to prevent patient exposure to falsified products," wrote Margaret Hamburg, foreign secretary of the Institute of Medicine, the health arm of the US National Academy of Sciences.

Scientists inspected the quality of about 16,800 samples of anti-malarials, anti-tuberculosis medicines, antibiotics and anti-leishmaniasis drugs and reported from 9 to 41 percent failed to meet the specifications.

Seven separate studies were carried out, primarily in low-resource settings, and included samples from public and private sources.

"The pandemic of falsified and substandard medicines is pervasive and underestimated, particularly in low and middle income countries, where drug regulatory systems are weak or non-existent," Jim Herrington from the University of North Carolina noted.

New methodologies to test drug quality are emerging and scientists reported the results of four investigations. Simple paper-based test cards proved to be an economical and portable method to identify very low quality anti-malarials.

More sophisticated approaches using fluorescent and luminescent techniques or other novel technologies can measure with greater precision but may be difficult to use in remote settings, the authors noted.

An urgent and coordinated international response is required to address the pandemic of poor quality drugs, the scientists maintained.

The findings were published online ahead of print by The American Journal of Tropical Medicine and Hygiene.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 21 2015 | 2:44 PM IST

Next Story